Healthcare Executive Faints During Oval Office Announcement
Gordon Findlay, Healthcare Executive of Novo Nordisk, fainted Thursday in the Oval Office during a weight loss drug announcement.
Incident Details
The event, centered on GLP-1 drugs, was paused as President Donald Trump and Dr. Mehmet Oz shifted their focus to Findlay. White House Press Secretary Karoline Leavitt confirmed the fainting but stated he is expected to recover.
"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted," Leavitt said. "The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Announcement Context
On the same day, President Trump announced a deal with Eli Lilly and Novo Nordisk to offer some obesity drugs at about $150 per month for Americans.
Aftermath
- Multiple speakers addressed the White House gathering.
- Findlay fainted during Eli Lilly CEO David Ricks' speech.
- The press was quickly escorted out while Dr. Kennedy sought medical aid for Findlay.
- The press conference resumed at 1:29 p.m.
Author's summary: During a major Oval Office event on affordable obesity drugs, Novo Nordisk’s executive fainted but recovered quickly, briefly halting the announcement.